Literature DB >> 23959367

Cancer: ADT and acute kidney injury-causal or casual relationship?

Matthew R Smith1.   

Abstract

A recent observational study has reported that androgen deprivation therapy for prostate cancer is associated with an increased risk of acute kidney injury. As a result of limited biological plausibility and critical measured and unmeasured confounders, the reported link is more likely to be casual than causal.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23959367     DOI： 10.1038/nrendo.2013.167

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  9 in total

1.  Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.

Authors:  Shabbir M H Alibhai; Henriette Breunis; Narhari Timilshina; Calvin Johnston; George Tomlinson; Ian Tannock; Murray Krahn; Neil E Fleshner; Padraig Warde; Sarah Duff Canning; Lawrence Klotz; Gary Naglie
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

Review 2.  An update on androgen deprivation therapy for prostate cancer.

Authors:  Nima Sharifi; James L Gulley; William L Dahut
Journal:  Endocr Relat Cancer       Date:  2010-10-29       Impact factor: 5.678

3.  Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.

Authors:  Nancy L Keating; A James O'Malley; Matthew R Smith
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

4.  Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer.

Authors:  Matthew R Smith; Simone Peart Boyce; Erick Moyneur; Mei Sheng Duh; Monika K Raut; Jane Brandman
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

5.  Risk of fracture after androgen deprivation for prostate cancer.

Authors:  Vahakn B Shahinian; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  N Engl J Med       Date:  2005-01-13       Impact factor: 91.245

Review 6.  Metabolic complications of androgen deprivation therapy for prostate cancer.

Authors:  Philip J Saylor; Matthew R Smith
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

7.  Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer.

Authors:  Francesco Lapi; Laurent Azoulay; M Tamim Niazi; Hui Yin; Serge Benayoun; Samy Suissa
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

Review 8.  Bisphosphonate nephrotoxicity.

Authors:  Mark A Perazella; Glen S Markowitz
Journal:  Kidney Int       Date:  2008-08-06       Impact factor: 10.612

9.  Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition.

Authors:  Matthew R Smith; Melissa Goode; Anthony L Zietman; Francis J McGovern; Hang Lee; Joel S Finkelstein
Journal:  J Clin Oncol       Date:  2004-07-01       Impact factor: 44.544
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.